CLINICAL_TRIALS
trial_result
· 2020-06-04
Clinical Trial Update: Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy [Phase 3]
Summary
Phase 3 follow-up study assessing safety and efficacy of brivaracetam in epilepsy completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2020-06-04